Literature DB >> 14172824

[DESIPRAMINE (PERTOFRAN) IN THE TREATMENT OF DEPRESSIONS WITH A PSYCHODYNAMIC ANALYSIS OF ITS THERAPEUTIC EFFECTS].

R ALNAES, J KRISTIANSEN.   

Abstract

Entities:  

Keywords:  ANTIDEPRESSIVE AGENTS; CLINICAL RESEARCH; DEPRESSION; DESIPRAMINE; IMIPRAMINE; PHARMACOLOGY; PSYCHOSES, MANIC-DEPRESSIVE; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1964        PMID: 14172824     DOI: 10.1007/BF00352878

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr        ISSN: 0003-9373


× No keyword cloud information.
  26 in total

1.  A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

Authors:  J ANGST
Journal:  Psychopharmacologia       Date:  1961-12-19

2.  [On the effect of Tofranil in prolonged personal trials].

Authors:  R DEGKWITZ
Journal:  Med Exp Int J Exp Med       Date:  1961

3.  A comparative study of selected antidepressant medications and EST.

Authors:  M GREENBLATT; G H GROSSER; H WECHSLER
Journal:  Am J Psychiatry       Date:  1962-08       Impact factor: 18.112

4.  The treatment of depressive conditions with imipramine (G 22355).

Authors:  H E LEHMANN; C H CAHN; R L DE VERTEUIL
Journal:  Can Psychiatr Assoc J       Date:  1958-10

5.  [Medicopsychological research on the effects of Tofranil on normal and sick persons].

Authors:  C FERVERS; D HUTHMACHER; K H REILING
Journal:  Z Psychother Med Psychol       Date:  1961-07

6.  [A pharmacologist looks at psychopharmacological tests].

Authors:  E JACOBSEN
Journal:  Nord Psykiatr Tidsskr       Date:  1962

7.  [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

Authors:  R KUHN
Journal:  Schweiz Med Wochenschr       Date:  1957-08-31

8.  [Clinical estimation of new psychopharmaca].

Authors:  G LUNDQUIST
Journal:  Nord Psykiatr Tidsskr       Date:  1962

9.  Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound.

Authors:  T A BAN; H E LEHMANN
Journal:  Can Med Assoc J       Date:  1962-06-02       Impact factor: 8.262

10.  Desmethylimipramine (G-35020) in the treatment of depression, pilot study in a general hospital and outpatient setting.

Authors:  A M MANN
Journal:  Can Med Assoc J       Date:  1962-03-17       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.